WELCOME TO SUDA LTD

  is a publicly listed Company on the Australian Securities Exchange (ASX:SUD) that is involved in the commercialisation of low-risk pharmaceutical projects.

SUDA’s focus is the delivery of drugs via the oral mucosa. Our business model has been designed around the development of low-risk pharmaceuticals using novel formulations of existing drugs that are off patent. We focus on re-formulation of these drugs to provide patentable products or a line extension for existing products.

We are fulfilling this strategy by the acquisition and development of technology that supports this model and can provide a pipeline of products in various stages of development. In addition, the further benefit of this business model is that it provides a strong foundation for the development of other drug candidates which may open the doors to lucrative licensing agreements.